Wat is de prijs voor I'rom Group Co., Ltd. (2372)

Het prijs van I'rom Group Co., Ltd. (2372) is $18.20

Wat is de marktkapitalisatie voor I'rom Group Co., Ltd. (2372)

Marktkapitalisatie voorI'rom Group Co., Ltd. (2372) is $220.35M

I'rom Group Co., Ltd. (2372) Aandelensplitsingen

I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.

Jaar	Splitsing	Vermenigvuldiging	Cumulatieve vermenigvuldiging
2013-09-26	10:1	x10	x30
2005-02-01	3:1	x3	x3

Jaar

Splitsing

Vermenigvuldiging

Cumulatieve vermenigvuldiging

2013-09-26

10:1

x10

x30

2005-02-01

3:1

Bedrijf	Aantal aandelen splitsingen	Cumulatieve vermenigvuldiging	Land
HCA Healthcare, Inc. HCA.US	0	-	US
Fresenius SE & Co. KGaA FRE.DE	0	-	DE
Dr. Sulaiman Al Habib Medical Services Group Company 4013.SR	0	-	SA
Tenet Healthcare Corporation THC.US	12	x7	US
IHH Healthcare Berhad 5225.KL	0	-	MY

Bedrijf

Aantal aandelen splitsingen

Cumulatieve vermenigvuldiging

Land